Discovery and Development of Influenza Virus Sialidase Inhibitor Relenza

作者: Robin Thomson , Mark von Itzstein

DOI: 10.1002/9780470929353.CH27

关键词:

摘要:

参考文章(87)
Michael Elliott, Zanamivir: from drug design to the clinic. Philosophical Transactions of the Royal Society B. ,vol. 356, pp. 1885- 1893 ,(2001) , 10.1098/RSTB.2001.1021
Susan M. Wintermeyer, Milap C. Nahata, Rimantadine: A Clinical Perspective: Annals of Pharmacotherapy. ,vol. 29, pp. 299- 310 ,(1995) , 10.1177/106002809502900312
Frances I. Smith, Peter Palese, Variation in Influenza Virus Genes Springer, Boston, MA. pp. 319- 359 ,(1989) , 10.1007/978-1-4613-0811-9_7
J.R. Rich, D. Gehle, M. von Itzstein, Design and synthesis of sialidase inhibitors for influenza virus infections Comprehensive Glycoscience#R##N#From Chemistry to Systems Biology. ,vol. 1, pp. 885- 922 ,(2007) , 10.1016/B978-044451967-2/00107-0
Avian Influenza A (H5N1) Infection in Humans The New England Journal of Medicine. ,vol. 353, pp. 1374- 1385 ,(2005) , 10.1056/NEJMRA052211
David P. Calfee, Amy W. Peng, Lindsey M. Cass, Monica Lobo, Frederick G. Hayden, Safety and Efficacy of Intravenous Zanamivir in Preventing Experimental Human Influenza A Virus Infection Antimicrobial Agents and Chemotherapy. ,vol. 43, pp. 1616- 1620 ,(1999) , 10.1128/AAC.43.7.1616
P.M. Colman, Influenza virus neuraminidase: structure, antibodies, and inhibitors. Protein Science. ,vol. 3, pp. 1687- 1696 ,(1994) , 10.1002/PRO.5560031007